By Product
Currency:CNY
2025/H1
Stock NameRevenueRatio
Preparation product470.46M34.59%
Other pharmaceutical and chemical products361.99M26.61%
Cefazal side chain active ester series297.6M21.88%
Series of Biopharmaceutical and characteristic API products230.2M16.92%
By Industry
Currency:CNY
2025/H1
Stock NameRevenueRatio
Intermediate segment662.94M48.74%
Preparation division476.16M35.01%
Characteristic raw material medicine235.35M17.30%
Other17.66M1.30%
Interdivisional offset-31.87M-2.34%
By Country/Region
Currency:CNY
2025/H1
Stock NameRevenueRatio
Domestic sales1.13B82.92%
Foreign sales232.35M17.08%